3 employees
Haystack Dx developed a complete solution to address the clinical unmet need to improve the diagnostic procedure for neuromuscular disorder.
2018
$250K
from 1 investors over 1 rounds
Haystack Dx raised $250K on April 22, 2021
Investors: Massachusetts Life Sciences Center